(19)
(11) EP 2 940 028 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.09.2017 Bulletin 2017/39

(45) Mention of the grant of the patent:
16.08.2017 Bulletin 2017/33

(21) Application number: 15161799.0

(22) Date of filing: 06.01.2004
(51) International Patent Classification (IPC): 
C07H 15/04(2006.01)
C07H 11/04(2006.01)
 C07H 5/02(2006.01)
C07H 13/04(2006.01)

(54)

CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE

BESTIMMTE AMINOALKYL-GLUCOSAMINID-PHOSPHATVERBINDUNGEN UND IHRE VERWENDUNG

COMPOSES D'AMINOALKYLE GLUCOSAMINIDE PHOSPHATE ET LEUR UTILISATION

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 06.01.2003 US 438585 P

(43) Date of publication of application:
04.11.2015 Bulletin 2015/45

(62) Application number of the earlier application in accordance with Art. 76 EPC:
04700403.1 / 1589934

(73) Proprietor: CORIXA CORPORATION
Wilmington, DE 19808 (US)

(72) Inventor:
  • Johnson, David A.
    Hamilton, MT Montana 59840 (US)

(74) Representative: HGF Limited 
4th Floor Merchant Exchange 17-19 Whitworth Street West
Manchester M1 5WG
Manchester M1 5WG (GB)


(56) References cited: : 
WO-A2-01/34617
US-B1- 6 355 257
 US-A- 5 597 573
   
  • PERSING D H ET AL: "TAKING TOLL: LIPID A MIMETICS AS ADJUVANTS AND IMMUNOMODULATORS", TRENDS IN MICROBIOLOGY, ELSEVIER SCIENCE LTD., KIDLINGTON, GB, vol. 10, no. 10, SUPPL, 1 January 2002 (2002-01-01), pages S32-S37, XP009067296, ISSN: 0966-842X, DOI: 10.1016/S0966-842X(02)02426-5
  • BAZIN H G ET AL: "The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 18, no. 20, 15 October 2008 (2008-10-15), pages 5350-5354, XP025562059, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2008.09.060 [retrieved on 2008-09-19]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).